• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCompass Therapeutics
    Picture of Compass Therapeutics logo

    CMPX — Compass Therapeutics News Story

    $0.760.000.00%
    us flag iconLast trade - 00:00
    HealthcareSmall CapSucker Stock
    • Market Cap
      $137.05m
    • Enterprise Value
      -$42.83m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CMPX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CMPX Dividends
    All News

    NASDAQ RESUMED AT 08:05 AM

    Picture of Compass Therapeutics logoCompass Therapeutics
    27/04/2026 13:05
    NASDAQ RESUMED  CMPX.O  AT 08:05 AM
    

    Recent news on Compass Therapeutics

    See all news
    • Brief: Compass Announces Inducement Grants Under Nasdaq Listing Rule

      14/10/2026 22:46
    • US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals

      23/09/2026 08:36
    • U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify

      22/09/2026 16:41
    • U.S. STOCKS ON THE MOVE-Vicor, Thor Industries, Lennar

      22/09/2026 14:14
    • Brief: Compass Therapeutics Provides Regulatory Update On Tovecimig In Biliary Tract Cancer Following FDA Feedback

      22/09/2026 14:12

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.